MICHAEL TERRIBILE: Open Payments
NPI 1720140643 · ROCK HILL, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,753 in 160 payments from 22 companies in 2025. Trend: 2023 $1,779 · 2024 $2,228 · 2025 $2,753
Food & beverage: $2,503Education: $251
| Company | Payments | Amount |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 22 | $372 |
| Janssen Biotech, Inc. | 9 | $323 |
| GENZYME CORPORATION | 11 | $290 |
| LEO Pharma Inc. | 14 | $246 |
| Galderma Laboratories, L.P. | 27 | $244 |
| Arcutis Biotherapeutics, Inc. | 18 | $214 |
| ABBVIE INC. | 12 | $195 |
| E.R. Squibb & Sons, L.L.C. | 10 | $168 |
| Organon LLC | 10 | $97 |
| PFIZER INC. | 5 | $91 |
Products named: TREMFYA, DUPIXENT, ILUMYA, Zoryve, SKYRIZI, Sotyktu, ADBRY, NEMLUVIO.
Industry payments across SC — which companies pay providers there.
